 PHILADELPHIA, Aug. 04, 2021 GLOBE NEWSWIRE -- Passage Bio, Inc. NASDAQ: PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that Bruce Goldsmith, Ph.D., president and chief executive officer of Passage Bio, will participate in a virtual panel presentation at the upcoming 12th Annual Wedbush PacGrow Healthcare Virtual Conference, taking place on August 10-12, 2021. 